MA moves to revoke license of pharmacy linked to meningitis outbreak
Inspectors have finished the first stage of an investigation at the compounding pharmacy that produced the steroids linked to the fungal meningitis outbreak, New England Compounding Center in Framingham. The inspection paints a picture of a pharmacy poised for problems. One claim is that batches of the steroid linked to deaths across the country were shipped out before NECC pharmacists had even confirmed they were safe.
- EHR Systems 'Immature, Costly,' AMA Says
- Anthem Blue Cross, 7 CA Health Systems Create New Challenger, Business Model
- Interstate Medical Licensure Effort Advances
- Data Points to Boom in Private HIX
- Few Winners Among MSSP Participants
- Better HCAHPS Scores Protect Revenue
- How to Build a Health Plan from Scratch
- Technology Lights Up Health Innovation Forum
- Insurers see cost hikes in Partners HealthCare (MA) mergers
- Malnourishment 'Epidemic' Plagues Hospitals? Really?